Bionanotechnology

This area is covered by the BioNanoNet (http://www.bionanonet.at), a ìsub-network” of NANONET-Styria. Interdisciplinary research is conducted in the field of drug development, elaborating new agents and application strategies within the network by using and developing advanced nanotechnologies. The BioNanoNet uses nanotechnology as a promising possibility for the application and characterisation of new active substances, with nanostructured materials playing a key role in drug delivery. The aim of these efforts in the medium term is to create new active substances and new treatment strategies for chronic-degenerative and infectious diseases.